Valutazione Della capacità d'Esercizio, Della funzionalità Respiratoria e Del Rimodellamento Ventricolare Sinistro in Pazienti Affetti da Scompenso Cardiaco a Frazione d'Eiezione Ridotta Trattati Con Sacubitril/Valsartan (Assessment of Exercise Capacity, Respiratory Function and Left Ventricular Remodeling in Patients with Reduced Ejection Fraction Heart Failure Treated with Sacubitril / Valsartan)
Latest Information Update: 12 Feb 2024
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
Most Recent Events
- 06 Feb 2024 Status changed from active, no longer recruiting to completed.
- 03 Feb 2021 Planned End Date changed from 15 Sep 2020 to 15 Sep 2021.
- 23 Jun 2020 New trial record